Skip to product information
1 of 2

My Store

Orforglipron - GLP-1 - 9mg x 60 Capsules

Orforglipron - GLP-1 - 9mg x 60 Capsules

Regular price $75.00 USD
Regular price Sale price $75.00 USD
Sale Sold out
Shipping calculated at checkout.

Orforglipron is an experimental, oral, daily GLP-1 receptor agonist.  Phase 3 trials have shown it effectively lowers blood sugar and promotes significant weight loss, with the safety profile being consistent with other GLP-1 drugs but with a higher incidence of mild-to-moderate gastrointestinal side effects like nausea and diarrhea, particularly during dose escalation.

Efficacy:

Weight loss: 
Orforglipron demonstrated superior weight reduction compared to placebo in obese patients, with one study showing an average loss of up to 12.4% at the highest dose.

Blood sugar control: 
It significantly lowered A1c levels in patients with type 2 diabetes, both as monotherapy and when used with insulin.

Other benefits: 
Studies also reported improvements in fasting serum glucose, systolic blood pressure, and certain cholesterol levels.Side effects.

Gastrointestinal issues: 
The most common side effects are mild to moderate gastrointestinal issues like nausea, diarrhea, vomiting, and constipation.

Dose-dependent: 
These side effects are often more pronounced during the initial period of dose escalation.

Serious adverse events: 
The proportion of participants experiencing serious adverse events did not differ between orforglipron and placebo groups in a specific trial. 
View full details